News

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-10-04-2017
Volume12
Issue 10

Spectrum Chemical in Distribution Deal with Cole-Parmer

Spectrum Chemical announced an agreement with Cole-Parmer for the distribution of Spectrum’s USP fine chemicals.

On Sep. 20, 2017, Spectrum Chemical, a manufacturer and distributor of fine chemicals, laboratory equipment, and supplies, announced a distribution agreement with Cole-Parmer, a manufacturer and distributor of fluid handling products, instrumentation, equipment, and supplies. Under the agreement, Cole Parmer will distribute Spectrum’s USP fine chemicals.

“The addition of Cole-Parmer to our distribution network adds laboratory instrument expertise and brand strength to our portfolio,” said Randy Burg, president and CEO of Spectrum, in a company press release.

Brian Buzinski, director of lab essentials business unit at Cole Parmer added, “As a trusted name in quality chemicals for more than four decades, we are happy to now offer Spectrum products to Cole-Parmer’s customers.”

Source: Spectrum Chemical 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content